HSBC Securities downgraded Colgate-Palmolive from Buy to Hold
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/28/2024 | $105.00 → $101.00 | Buy → Hold | Stifel |
| 9/24/2024 | $121.00 | Overweight | Piper Sandler |
| 9/16/2024 | $100.00 | Equal Weight → Underweight | Wells Fargo |
| 9/9/2024 | $107.00 → $109.00 | Buy → Hold | Deutsche Bank |
| 7/26/2024 | Buy → Hold | HSBC Securities | |
| 7/24/2024 | $103.00 → $95.00 | Buy → Hold | Jefferies |
| 7/23/2024 | $110.00 | Buy | TD Cowen |
| 6/24/2024 | $109.00 | Outperform | Exane BNP Paribas |
Stifel downgraded Colgate-Palmolive from Buy to Hold and set a new price target of $101.00 from $105.00 previously
Piper Sandler initiated coverage of Colgate-Palmolive with a rating of Overweight and set a new price target of $121.00
Wells Fargo downgraded Colgate-Palmolive from Equal Weight to Underweight and set a new price target of $100.00
Colgate-Palmolive (NYSE:CL) Chairman, President and CEO, Noel Wallace, will present on Wednesday, September 3, 2025 at 9:00 a.m. ET at the Barclays 2025 Global Consumer Staples Conference. Investors may access a live webcast of this presentation and the presentation slides on Colgate's website at http://www.colgatepalmolive.com. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center page of Colgate's website. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Hom
Colgate-Palmolive Company (NYSE:CL): Net sales increased 1.0%; Organic sales* increased 1.8%, including a 0.6% negative impact from lower private label pet sales GAAP EPS increased 2% to $0.91; Base Business EPS* increased 1% to $0.92 GAAP Gross profit margin decreased 50 basis points to 60.1%; Base Business Gross profit margin* decreased 70 basis points to 60.1% Net cash provided by operations was $1,484 million for the first six months of 2025 The Company's leadership in toothpaste continued with its global market share at 41.1% year to date The Company's leadership in manual toothbrushes continued with its global market share at 32.4% year to date The Company upd
Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 second quarter earnings conference call on Friday, August 1, 2025, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-presentations. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website. * * * C
4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)
4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)
4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)
10-Q - COLGATE PALMOLIVE CO (0000021665) (Filer)
8-K - COLGATE PALMOLIVE CO (0000021665) (Filer)
11-K - COLGATE PALMOLIVE CO (0000021665) (Filer)
Colgate-Palmolive Company (NYSE:CL): Net sales increased 1.0%; Organic sales* increased 1.8%, including a 0.6% negative impact from lower private label pet sales GAAP EPS increased 2% to $0.91; Base Business EPS* increased 1% to $0.92 GAAP Gross profit margin decreased 50 basis points to 60.1%; Base Business Gross profit margin* decreased 70 basis points to 60.1% Net cash provided by operations was $1,484 million for the first six months of 2025 The Company's leadership in toothpaste continued with its global market share at 41.1% year to date The Company's leadership in manual toothbrushes continued with its global market share at 32.4% year to date The Company upd
Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 second quarter earnings conference call on Friday, August 1, 2025, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-presentations. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website. * * * C
The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.52 per common share, payable on August 15, 2025, to shareholders of record on July 18, 2025. The Company has paid uninterrupted dividends on its common stock since 1895. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed St
The American Dental Association Foundation's Initiative, with Exclusive National Sponsors Henry Schein and Colgate-Palmolive, Continues to Expand Its Reach, With Nearly 325,500 Children Expected to Receive Care Throughout 2025 The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) program, which officially launched on Friday, February 7, at the 2025 national kick-off event at Meharry Medical College School of Dentistry. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than 9.5 million underserved children in the U.S. This press release features multimedia. Vi
IRVINE, Calif., March 12, 2024 /PRNewswire/ -- ZO® Skin Health, a premium clinical dermatological skincare brand distributed globally through physicians and skincare professionals, today announced the appointment of Justin Skala as Chief Executive Officer. Mr. Skala brings more than 35 years of leadership experience growing high efficacy products through the professional channel, including driving the expansion of the personal care category over his tenure at Colgate-Palmolive, Inc. (NYSE:CL). He succeeds Mark Williams who will continue to serve the company on its Board of Directors.
Colgate-Palmolive Company (NYSE:CL) today announced that its Board of Directors has appointed Lorrie Norrington as Lead Independent Director, effective March 1, 2023. Ms. Norrington will succeed Stephen I. Sadove, the Company's current Lead Independent Director. Mr. Sadove will remain on the Audit and Personnel and Organization Committees of the Colgate Board of Directors. Ms. Norrington joined the Company's Board in September 2015 and currently serves as Chair of the Nominating, Governance and Corporate Responsibility Committee. She brings extensive global corporate leadership, digital, e-commerce and ESG experience to this role, including her experience in several senior management roles
SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)
SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)
SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)